Nelli Grigorievna Prikhodchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nelli Grigorievna Prikhodchenko has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Tatyana Alexandrovna Shumatova
Pacific State Medical University
15 shared publications - Daria Vadimovna Kovalenko
Pacific State Medical University
5 shared publications - E. S. Zernova
Pacific State Medical University
5 shared publications T. A. Shumatova
Pacific State Medical University
5 shared publications- Antonina Nee
Pacific State Medical University
3 shared publications D.V. Kovalenko
3 shared publications
Latest Publications
- 16 May 2026
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 81 (1) , 52-59
The role of CYP3A4 polymorphic variants in the development of increased epithelial permeability in children with cow milk allergy: results of the observational cross-sectional study
Background. The continuing increase in the prevalence and severity of allergic diseases determines the relevance of the search for new approaches to their treatment and prevention. One of the leading areas is the study of the epithelial permeability role, including disorders in the cytochrome system that contribute to the formation of increased epithelial permeability and the development of allergies. Aims — to determine the role of the CYP3A4 gene polymorphism (rs2740574) in the development of increased epithelial permeability in children with food allergy to cow’s milk (CMA). Methods. Observational cross-sectional study of infants with a verified diagnosis of food allergy to cow’s milk (main group, n = 30). The study period was from 01.12.2023 to 30.12.2024. The target indicator of the study was the CYP3A4*1B polymorphism (rs2740574; c.-392CT) of the CYP3A4 gene (rs2740574) in children with CMA in blood lymphocytes and the level of cytochrome P450 3A4 (CYP3A4) in the serum. Additional indicators were the intestinal permeability marker zonulin in the blood serum and feces. Statistical analysis of the results - the difference in the distributions of polymorphic variants between the samples using Fisher’s exact test. Pairwise comparison of genotype and allele frequencies in the groups of patients and healthy people was performed using the chi-square test for contingency tables with Yates’ correction for continuity. The data of the variables are presented as the median and quartiles (Me (Q1; Q3)), the nonparametric Mann–Whitney test (U) was calculated to compare quantitative indicators. Differences are significant at p 0.05. Correlation analysis was performed to determine linear relationships between quantitative and between quantitative and qualitative binary indicators. Results. A statistically significant increase in the frequency of the pathological allele G in patients of the main group by 2.47 times was obtained (χ2 = 6.173; p = 0.001). Serum zonulin levels did not show statistically significant differences in patients with CMA compared to the group of healthy children (U = 0.065), but were statistically significantly higher in the group of children with skin manifestations of CMA compared to patients with isolated gastrointestinal manifestations (144.33 ng/ml (Q1–Q3: 126.32–151.78) and 118.78 ng/ml (Q1–Q3: 108.67–136.24) respectively; p 0.05). The fecal zonulin level in our study was significantly 1.9 times higher than in the group of healthy children, U = 0.0025, regardless of the clinical phenotype of CMA (1.39 ng/ml (Q1–Q3: 1.18–1.61) and 1.45 ng/ml (Q1–Q3: 1.14–1.58) respectively; p 0.05). There were no statistically significant (p = 0.071) differences in the CYP3A4 content in the serum of PA patients (Me = 0.18 ng/ml; Q1–Q3: 0.13–0.33) and children in the control group (Me = 0.17 ng/ml; Q1–Q3: 0.12–0.20). The conducted correlation analysis showed a significant association of the 392G allele of the CYP3A41B gene with changes in the level of all determined indicators. Conclusions. The results indicate the contribution of cytochrome system disorders in children with increased epithelial permeability. Understanding the molecular mechanism responsible for epithelial barrier defects is important in developing new treatments for food allergies and allergopathology.
- 16 May 2026
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 81 (1) , 52-59
The role of CYP3A4 polymorphic variants in the development of increased epithelial permeability in children with cow milk allergy: results of the observational cross-sectional study
Background. The continuing increase in the prevalence and severity of allergic diseases determines the relevance of the search for new approaches to their treatment and prevention. One of the leading areas is the study of the epithelial permeability role, including disorders in the cytochrome system that contribute to the formation of increased epithelial permeability and the development of allergies. Aims — to determine the role of the CYP3A4 gene polymorphism (rs2740574) in the development of increased epithelial permeability in children with food allergy to cow’s milk (CMA). Methods. Observational cross-sectional study of infants with a verified diagnosis of food allergy to cow’s milk (main group, n = 30). The study period was from 01.12.2023 to 30.12.2024. The target indicator of the study was the CYP3A4*1B polymorphism (rs2740574; c.-392CT) of the CYP3A4 gene (rs2740574) in children with CMA in blood lymphocytes and the level of cytochrome P450 3A4 (CYP3A4) in the serum. Additional indicators were the intestinal permeability marker zonulin in the blood serum and feces. Statistical analysis of the results - the difference in the distributions of polymorphic variants between the samples using Fisher’s exact test. Pairwise comparison of genotype and allele frequencies in the groups of patients and healthy people was performed using the chi-square test for contingency tables with Yates’ correction for continuity. The data of the variables are presented as the median and quartiles (Me (Q1; Q3)), the nonparametric Mann–Whitney test (U) was calculated to compare quantitative indicators. Differences are significant at p 0.05. Correlation analysis was performed to determine linear relationships between quantitative and between quantitative and qualitative binary indicators. Results. A statistically significant increase in the frequency of the pathological allele G in patients of the main group by 2.47 times was obtained (χ2 = 6.173; p = 0.001). Serum zonulin levels did not show statistically significant differences in patients with CMA compared to the group of healthy children (U = 0.065), but were statistically significantly higher in the group of children with skin manifestations of CMA compared to patients with isolated gastrointestinal manifestations (144.33 ng/ml (Q1–Q3: 126.32–151.78) and 118.78 ng/ml (Q1–Q3: 108.67–136.24) respectively; p 0.05). The fecal zonulin level in our study was significantly 1.9 times higher than in the group of healthy children, U = 0.0025, regardless of the clinical phenotype of CMA (1.39 ng/ml (Q1–Q3: 1.18–1.61) and 1.45 ng/ml (Q1–Q3: 1.14–1.58) respectively; p 0.05). There were no statistically significant (p = 0.071) differences in the CYP3A4 content in the serum of PA patients (Me = 0.18 ng/ml; Q1–Q3: 0.13–0.33) and children in the control group (Me = 0.17 ng/ml; Q1–Q3: 0.12–0.20). The conducted correlation analysis showed a significant association of the 392G allele of the CYP3A41B gene with changes in the level of all determined indicators. Conclusions. The results indicate the contribution of cytochrome system disorders in children with increased epithelial permeability. Understanding the molecular mechanism responsible for epithelial barrier defects is important in developing new treatments for food allergies and allergopathology.
- 25 April 2026
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (2)
Faecal calprotectin and circulating tight junction protein in children with gastrointestinal food allergy
Recent studies have confirmed that increased intestinal permeability syndrome plays a key role in the pathogenesis of allergic diseases, while peripheral tight junction proteins like ZO-1 may serve as potential biomarkers for assessing gut barrier integrity. The aim of the study. To evaluate serum ZO-1 levels as a marker of epithelial barrier dysfunction in children with gut barrier impairment and food allergy. Materials and methods. The study included 27 children with cow’s milk protein allergy (CMPA, Group I) aged 1 month to 3 years and 20 healthy controls (Group II). Serum ZO-1 and fecal calprotectin (FC) were measured by ELIZA. Statistical analysis used MannWhitney U test, Spearman’s correlation, and ROC analysis. Results. Gastrointestinal symptom severity (GSS) was scored based n crying, regurgitation, stool, etc. Group I showed significantly higher GSS (Ме=13, Q1-Q3:7–18) versus controls (Ме=3, Q1-Q3:1–4,5). Serum ZO-1 levels were significantly lower in CMPA patients (Ме=0,007 ng/mL, Q1-Q3:0–0,031) compared to controls (Ме=0,033 ng/mL, Q1-Q3:0,027–0,135; p<0,05). FC levels also differed significantly: 286 μg/g (Group I) vs 87 μg/g (controls; p<0,001). Inverse correlations were found between ZO-1 and FC (r=-0,675; p<0,01) and between ZO-1 and GSS (r=-0,605; p<0.05). Conclusion. Decreased ZO-1 levels and elevated fecal calprotectin confirm intestinal barrier damage in CMPA patients. ZO-1 serves as a reliable marker of barrier integrity, while its combination with FC enhances diagnostic value for predicting allergy progression and atopic march risk.
- 25 April 2026
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (2)
Faecal calprotectin and circulating tight junction protein in children with gastrointestinal food allergy
Recent studies have confirmed that increased intestinal permeability syndrome plays a key role in the pathogenesis of allergic diseases, while peripheral tight junction proteins like ZO-1 may serve as potential biomarkers for assessing gut barrier integrity. The aim of the study. To evaluate serum ZO-1 levels as a marker of epithelial barrier dysfunction in children with gut barrier impairment and food allergy. Materials and methods. The study included 27 children with cow’s milk protein allergy (CMPA, Group I) aged 1 month to 3 years and 20 healthy controls (Group II). Serum ZO-1 and fecal calprotectin (FC) were measured by ELIZA. Statistical analysis used MannWhitney U test, Spearman’s correlation, and ROC analysis. Results. Gastrointestinal symptom severity (GSS) was scored based n crying, regurgitation, stool, etc. Group I showed significantly higher GSS (Ме=13, Q1-Q3:7–18) versus controls (Ме=3, Q1-Q3:1–4,5). Serum ZO-1 levels were significantly lower in CMPA patients (Ме=0,007 ng/mL, Q1-Q3:0–0,031) compared to controls (Ме=0,033 ng/mL, Q1-Q3:0,027–0,135; p<0,05). FC levels also differed significantly: 286 μg/g (Group I) vs 87 μg/g (controls; p<0,001). Inverse correlations were found between ZO-1 and FC (r=-0,675; p<0,01) and between ZO-1 and GSS (r=-0,605; p<0.05). Conclusion. Decreased ZO-1 levels and elevated fecal calprotectin confirm intestinal barrier damage in CMPA patients. ZO-1 serves as a reliable marker of barrier integrity, while its combination with FC enhances diagnostic value for predicting allergy progression and atopic march risk.
- Open Access
- 18 January 2026
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 24 (6) , 407-412
Evolution of Approaches to Primary Prevention of Food Allergies among Children: from Elimination to Early Allergens Introduction
Food allergy (FA) remains global pediatric issue affecting up to 8% of the child population, it has significant negative impact on the quality of life of children and their families. In recent years, the paradigm of FA prevention has changed dramatically: from elimination strategies to early allergen introduction and immune response modulation. This article provides the analysis of recent scientific data and consensus statements from professional societies that focus on the primary FA prevention strategies efficacy in children.
- 18 January 2026
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 24 (6) , 407-412
Open AccessEvolution of Approaches to Primary Prevention of Food Allergies among Children: from Elimination to Early Allergens Introduction
Food allergy (FA) remains global pediatric issue affecting up to 8% of the child population, it has significant negative impact on the quality of life of children and their families. In recent years, the paradigm of FA prevention has changed dramatically: from elimination strategies to early allergen introduction and immune response modulation. This article provides the analysis of recent scientific data and consensus statements from professional societies that focus on the primary FA prevention strategies efficacy in children.
- 10 December 2025
- Published by Pacific State Medical University in Pacific Medical Journal
- No. 3
I-FABP and fecal calprotectin in necrotizing enterocolitis in newborns: A prospective clinical study
Objective. To evaluate the diagnostic and prognostic value of I-FABP (in serum and urine) and fecal calprotectin as biomarkers for the early diagnosis of necrotizing enterocolitis (NEC) in newborns. Materials and methods. A prospective study involving 42 newborns was conducted. The main group included 12 newborns with a confirmed NEC diagnosis. The comparison group included 18 newborns with intestinal symptoms without NEC. The control group consisted of 12 healthy newborns. The levels of I-FABP in serum and urine, as well as fecal calprotectin, were measured in all the subjects. Receiver Operating Characteristic (ROC) analysis was used to assess the diagnostic accuracy of the markers by calculating the area under the curve (AUC), sensitivity, and specificity. Results. Levels of serum I-FABP, urinary I-FABP, and fecal calprotectin in NEC patients were significantly higher than those in the comparison and control groups ( p < 0.001). ROC analysis demonstrated high diagnostic value for each biomarker: serum I-FABP – AUC = 0.91; urinary I-FABP – AUC = 0.76; fecal calprotectin – AUC = 0.86. The combination of the investigated markers showed the highest efficacy, with an AUC of 0.93, a sensitivity of 93.5%, and a specificity of 91.7%. Conclusion. Necrotizing enterocolitis is a life-threatening condition, whose early diagnosis remains challenging. The study results confirm the high informativity of I-FABP and fecal calprotectin as biomarkers of intestinal injury. The combination of these markers demonstrates exceptionally high diagnostic accuracy (sensitivity 93.5%, specificity 91.7%), supporting their use in clinical practice to improve the early diagnosis and management of NEC patients.
- 10 December 2025
- Published by Pacific State Medical University in Pacific Medical Journal
- No. 3
I-FABP and fecal calprotectin in necrotizing enterocolitis in newborns: A prospective clinical study
Objective. To evaluate the diagnostic and prognostic value of I-FABP (in serum and urine) and fecal calprotectin as biomarkers for the early diagnosis of necrotizing enterocolitis (NEC) in newborns. Materials and methods. A prospective study involving 42 newborns was conducted. The main group included 12 newborns with a confirmed NEC diagnosis. The comparison group included 18 newborns with intestinal symptoms without NEC. The control group consisted of 12 healthy newborns. The levels of I-FABP in serum and urine, as well as fecal calprotectin, were measured in all the subjects. Receiver Operating Characteristic (ROC) analysis was used to assess the diagnostic accuracy of the markers by calculating the area under the curve (AUC), sensitivity, and specificity. Results. Levels of serum I-FABP, urinary I-FABP, and fecal calprotectin in NEC patients were significantly higher than those in the comparison and control groups ( p < 0.001). ROC analysis demonstrated high diagnostic value for each biomarker: serum I-FABP – AUC = 0.91; urinary I-FABP – AUC = 0.76; fecal calprotectin – AUC = 0.86. The combination of the investigated markers showed the highest efficacy, with an AUC of 0.93, a sensitivity of 93.5%, and a specificity of 91.7%. Conclusion. Necrotizing enterocolitis is a life-threatening condition, whose early diagnosis remains challenging. The study results confirm the high informativity of I-FABP and fecal calprotectin as biomarkers of intestinal injury. The combination of these markers demonstrates exceptionally high diagnostic accuracy (sensitivity 93.5%, specificity 91.7%), supporting their use in clinical practice to improve the early diagnosis and management of NEC patients.
- Open Access
- 5 October 2024
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 3,p. 31-41
Fecal zonulin as a prognostic marker of atopic march in children with food allergy
Introduction. The onset of allergic diseases most often occurs in early childhood with the onset of food allergies, which can subsequently lead to the implementation of the atopic march. Increased intestinal permeability with high production of zonulin, the main moderator of intestinal tight junctions, can be an important link in the development of comorbid allergic diseases.Material and methods. In order to study the significance of fecal zonulin as a marker for predicting the atopic march in children with food allergy, a cross-sectional retrospective study was conducted on 73 children aged 5 years who were diagnosed with food allergy (FA) to cow’s milk proteins in the first year of life. In all children, when the diagnosis was made in the first year of life, the content of zonulin in feces was determined using the ELISA method.Results. As a result of dynamic observation, all children with food allergy were divided into 2 groups: the first group consisted of children with food allergy who developed allergic rhinitis and/or bronchial asthma within 5 years (group I, n = 39), group 2 consisted of 34 children with food allergy who did not implement the atopic march within 5 years of observation (group II, n = 34). Our study showed statistically significant differences in the fecal zonulin level in the first year of life: group I Me = 2.39 ng/ml (Q1-Q3: 1.78–2.65 ng/ml), group II Me = 1.85 ng/ml (Q1-Q3: 0.49–0.91 ng/ml), p = 0.034. Strong direct correlations were found (Spearman correlation coefficient S = 0.681 (p < 0.05)) between the zonulin level in feces at the onset of the disease and the development of allergic rhinitis and/or bronchial asthma up to 5 years of age, the data were confirmed by comparing the areas under the curves during ROC analysis, AUC in the study of fecal zonulin as a prognostic marker of the risk of atopic march in children is 0.887, the optimal threshold (cutoff point) is 1.94 ng/ml.Conclusions. Fecal zonulin level in children with food allergy can be an effective prognostic marker of atopic march development, its values in feces above 1.94 ng/ml allow us to predict with a high degree of probability the risk of atopic march development in children with food allergy to cow’s milk proteins within 5 years
- 5 October 2024
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 3,p. 31-41
Open AccessFecal zonulin as a prognostic marker of atopic march in children with food allergy
Introduction. The onset of allergic diseases most often occurs in early childhood with the onset of food allergies, which can subsequently lead to the implementation of the atopic march. Increased intestinal permeability with high production of zonulin, the main moderator of intestinal tight junctions, can be an important link in the development of comorbid allergic diseases.Material and methods. In order to study the significance of fecal zonulin as a marker for predicting the atopic march in children with food allergy, a cross-sectional retrospective study was conducted on 73 children aged 5 years who were diagnosed with food allergy (FA) to cow’s milk proteins in the first year of life. In all children, when the diagnosis was made in the first year of life, the content of zonulin in feces was determined using the ELISA method.Results. As a result of dynamic observation, all children with food allergy were divided into 2 groups: the first group consisted of children with food allergy who developed allergic rhinitis and/or bronchial asthma within 5 years (group I, n = 39), group 2 consisted of 34 children with food allergy who did not implement the atopic march within 5 years of observation (group II, n = 34). Our study showed statistically significant differences in the fecal zonulin level in the first year of life: group I Me = 2.39 ng/ml (Q1-Q3: 1.78–2.65 ng/ml), group II Me = 1.85 ng/ml (Q1-Q3: 0.49–0.91 ng/ml), p = 0.034. Strong direct correlations were found (Spearman correlation coefficient S = 0.681 (p < 0.05)) between the zonulin level in feces at the onset of the disease and the development of allergic rhinitis and/or bronchial asthma up to 5 years of age, the data were confirmed by comparing the areas under the curves during ROC analysis, AUC in the study of fecal zonulin as a prognostic marker of the risk of atopic march in children is 0.887, the optimal threshold (cutoff point) is 1.94 ng/ml.Conclusions. Fecal zonulin level in children with food allergy can be an effective prognostic marker of atopic march development, its values in feces above 1.94 ng/ml allow us to predict with a high degree of probability the risk of atopic march development in children with food allergy to cow’s milk proteins within 5 years
- Open Access
- 1 January 2024
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №6 2024,p. 1
FATTY ACID BINDING PROTEIN AS A PREDICTOR OF EXACERBATION OF PROTEIN-INDUCED ENTEROPATHY IN CHILDREN
- 1 January 2024
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №6 2024,p. 1
Open AccessFATTY ACID BINDING PROTEIN AS A PREDICTOR OF EXACERBATION OF PROTEIN-INDUCED ENTEROPATHY IN CHILDREN
- Open Access
- 1 January 2024
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №5 2024,p. 90
FATTY ACID BINDING PROTEINS – A NEW DIAGNOSTIC METHOD
- 1 January 2024
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №5 2024,p. 90
Open AccessFATTY ACID BINDING PROTEINS – A NEW DIAGNOSTIC METHOD
- Open Access
- 1 January 2023
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №5 2023,p. 4
VITAMIN D AND ITS GENETIC REGULATION IN PATIENTS WITH MALABSORPTION
- 1 January 2023
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №5 2023,p. 4
Open AccessVITAMIN D AND ITS GENETIC REGULATION IN PATIENTS WITH MALABSORPTION